Insider · CIK 0001661400
Nolan Lisa
Reports to the SEC for 2 companies · NEW YORK, NY
Transactions
10
Companies
2
Filings
7
CIK
0001661400
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2019-02-28 | IRDOpus Genetics, Inc.M Exercise/Conversion | — |
| 2019-02-28 | IRDOpus Genetics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2019-01-30 | IRDOpus Genetics, Inc.P Purchase | +$13K |
| 2019-01-25 | IRDOpus Genetics, Inc. · Stock Option (right to buy)A Award | — |
| 2018-02-28 | IRDOpus Genetics, Inc.M Exercise/Conversion | — |
| 2018-02-28 | IRDOpus Genetics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2018-01-26 | IRDOpus Genetics, Inc. · Stock Option (right to buy)A Award | — |
| 2017-01-20 | IRDOpus Genetics, Inc. · Stock Option (right to buy)A Award | — |
| 2017-01-20 | IRDOpus Genetics, Inc. · Restricted Stock UnitsA Award | — |
| 2016-07-06 | IRDOpus Genetics, Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4Nolan Lisa0001140361-19-004276SEC(opens sec.gov)
- 4Nolan Lisa0001140361-19-002080SEC(opens sec.gov)
- 4Nolan Lisa0001140361-19-001635SEC(opens sec.gov)
- 4Nolan Lisa0001140361-18-011675SEC(opens sec.gov)
- 4Nolan Lisa0001140361-18-003894SEC(opens sec.gov)
- 4REXAHN PHARMACEUTICALS, INC.0001140361-17-002734SEC(opens sec.gov)
- 4REXAHN PHARMACEUTICALS, INC.0001140361-16-072011SEC(opens sec.gov)
Companies
Address
C/O RELMADA THERAPEUTICS, INC. 757 THIRD AVENUE, SUITE 2018
NEW YORK, NY, 10017